These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 903183)

  • 41. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
    Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naringenin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt's lymphoma cells.
    Kim JH; Lee JK
    Arch Pharm Res; 2015 Nov; 38(11):2042-8. PubMed ID: 26100136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo and in vitro studies of immunotherapy of nasopharyngeal carcinoma with transfer factor.
    Goldenberg GJ; Brandes LJ
    Cancer Res; 1976 Feb; 36(2 pt 2):720-3. PubMed ID: 1253157
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma.
    Judson SC; Henle W; Henle G
    N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
    Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
    Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-barr virus induction by a serum factor: IV. Ubiquitous occurrence of the factor within vertebrates and its interaction with defined lymphoid cell lines.
    Wittmann P; Höfler P; Bauer G
    Int J Cancer; 1982 Oct; 30(4):503-10. PubMed ID: 6292119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sesamolin enhances NK cell lysis activity by increasing the expression of NKG2D ligands on Burkitt's lymphoma cells.
    Kim JH; Lee JK
    Int Immunopharmacol; 2015 Oct; 28(2):977-84. PubMed ID: 26298637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cells.
    Dorval G; Bourkas AE; Menezes J
    Clin Exp Immunol; 1979 Sep; 37(3):477-85. PubMed ID: 92381
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined modality treatment of American Burkitt's lymphoma.
    Ziegler JL; DeVita VT; Graw RG; Herzig G; Leventhal BG; Levine AS; Pomeroy TC
    Cancer; 1976 Dec; 38(6):2225-31. PubMed ID: 1036716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antineoplastic effects of nutrient mixture on raji and jurkat t cells: the two highly aggressive non Hodgkin's lymphoma cell lines.
    Roomi MW; Bhanap BA; Roomi NW; Rath M; Niedzwiecki A
    Exp Oncol; 2009 Sep; 31(3):149-55. PubMed ID: 19783966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
    Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
    Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial.
    Ziegler JL; Magrath IT
    Natl Cancer Inst Monogr; 1973 Dec; 39():199-202. PubMed ID: 4595317
    [No Abstract]   [Full Text] [Related]  

  • 56. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    Int J Cancer; 1984 Sep; 34(3):339-48. PubMed ID: 6090321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remission.
    Gunvén P; Klein G; Ziegler JL; Magrath IT; Olweny CL; Henle W; Henle G; Svedmyr A; Demissie A
    J Natl Cancer Inst; 1978 Jan; 60(1):31-7. PubMed ID: 203706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to Epstein-Barr virus (EBV) in American patients with Burkitt's lymphoma.
    Levine PH; O'Conor GT; Bernard CW
    Cancer; 1972 Sep; 30(3):610-5. PubMed ID: 4342405
    [No Abstract]   [Full Text] [Related]  

  • 59. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH; Revillard JP; Magaud JP; Lenoir G; Vuillaume M; Manel AM; Vincent C; Bryon PA
    J Natl Cancer Inst; 1987 Feb; 78(2):235-42. PubMed ID: 3027441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remission.
    Oldham RK; Weiner RS; Mathé G; Breard J; Simmler MC; Carde P; Herberman RB
    Int J Cancer; 1976 Mar; 17(3):326-37. PubMed ID: 1062362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.